rfXcel Corporation, a leading provider of ePedigree Management solutions that allow manufacturers, distributors, and retailers to track the chain of custody of prescription drugs through the pharmaceutical supply chain, today announced that R&S Northeast has purchased and are in production using rfXcel’s ePedigree Management solution to protect its supply chain from the threat of counterfeit drugs.
Based in Philadelphia, PA, R&S Northeast, LLC, has been a supplier of Brand and Generic Pharmaceuticals and various healthcare products since 1973.
To support compliance with existing Pedigree Laws including Florida and Nebraska, as well as future compliance with California’s pending 2011 ePedigree and serialization requirements, R&S Northeast selected rfXcel’s ePedigree Management solution. rfXcel was selected for its certified conformance to the EPCglobal Drug Pedigree Standard, and its successful track record in getting its existing customers into production, currently generating Pedigrees for all 50 states.
“R&S Northeast takes pride in our high level of customer service and in our ability to deliver flawlessly for our customers”, said Leo Moskoff, COO of R&S Northeast, “Likewise, we choose our suppliers on that basis - rfXcel has not only met but exceeded our expectations, as they were able to get us into production rapidly and were always there when we needed them”.
“In selecting rfXcel’s easy to use and production-worthy ePedigree Management solution, R&S has taken a major step forward in securing its supply chain from the threat of counterfeits”
